Status | Study |
Completed |
Study Name: Preterm Infants and Nephrocalcinosis Condition: Prematurity Nephrocalcinosis Date: 2015-05-01 |
Terminated |
Study Name: ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study Condition: Sarcoidosis Hypercalcemia Due to Sarcoidosis Date: 2014-05-30 Interventions: Drug: ACTHAR Gel (adrenocorticotropic hormone) ACTHAR GEL (adrenocorticotropic hormone) 80 units subcuta |
Completed |
Study Name: Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature Condition: Nephrocalcinosis Date: 2012-12-20 Interventions: Drug: Potassium Citrate Potass |
Terminated |
Study Name: Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients Condition: Primary Hypomagnesemia (Disorder) Date: 2011-08-24 Interventions: Drug: Magnesium Sulfate 8 grams over 4 or 8 hours depending on randomization |
Terminated |
Study Name: Renal Tubular Acidosis in Incident Renal Transplant Recipients Condition: Renal Transplant Disorder Date: 2011-01-25 |
Withdrawn |
Study Name: International Registry for Primary Hyperoxaluria Condition: Primary Hyperoxaluria Nephrocalcinosis Date: 2009-04-02 |
Completed |
Study Name: Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants Condition: Nephrocalcinosis Date: 2005-11-03 Interventions: Drug: Alkaline citrate Prophylactic alkaline citrate medication during the first 8 weeks of life versus |
Recruiting |
Study Name: Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis Condition: Nephrocalcinosis Renal Calculi Date: 2005-09-12 Interventions: Other: videotape for mapping of renal anatomy and papillary biopsy Subjects who enroll in this study wil |